Inovio Pharmaceuticals, Inc. INO
1.48 USD +0.03 (+1.72%)
At closeNov 11, 2026, 7:59 PM EST
1.41 -0.07 -4.41%
After hours · Nov 11, 7:59 PM ET
1.30 Day range 1.48
0.56 52-week range 2.72
- YTD
- -15.23%
- 1 year
- -26.25%
News
benzinga.com Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $6 Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $8 to $6.
prnewswire.com INOVIO to Participate in Upcoming Investor Conferences PLYMOUTH MEETING, Pa., Nov. 11, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from…
marketbeat.com Inovio Pharmaceuticals Q3 Earnings Call Highlights Inovio Pharmaceuticals NASDAQ: INO is preparing to launch its first approved product, VOCERYQ, after the Food and Drug Administration granted accelerated approval for the treatment of adults with…
seekingalpha.com Inovio Pharmaceuticals, Inc. (INO) Q3 2026 Earnings Call Transcript Inovio Pharmaceuticals, Inc. (INO) Q3 2026 Earnings Call Transcript
prnewswire.com INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights VOCERYQ™ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) granted accelerated approval by U.S. Food and Drug Administration (FDA) to reduce the frequency of surgery in adults with…
benzinga.com Inovio Pharmaceuticals Q3 EPS $(0.50) Misses $(0.21) Estimate, Sales $298.901K Miss $3.631M Estimate Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.21) by 138.1 percent. This is a 42.53 percent increase over…- benzinga.com Jefferies Maintains Buy on Inovio Pharmaceuticals, Raises Price Target to $8 Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 19.5% to $0.36 during Friday's pre-market session. The company's market cap stands at $27.1 million. Eton Pharmaceuticals (NASDAQ:ETON)…
prnewswire.com INOVIO Announces Pricing of Approximately $75 Million Public Offering PLYMOUTH MEETING, Pa., Nov. 5, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and…
benzinga.com INOVIO Pharmaceuticals Commences Common Stock Offering; No Terms Disclosed INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
prnewswire.com INOVIO Announces Proposed Public Offering of its Common Stock PLYMOUTH MEETING, Pa., Nov. 5, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and…
seekingalpha.com Inovio: Upgrading To 'Buy' On Voceryq Accelerated Approval RRP And Competitive Advantages Inovio Pharmaceuticals receives FDA Accelerated Approval for VOCERYQ [INO-3107] in recurrent respiratory papillomatosis, prompting a rating upgrade from "Hold" to "Buy." VOCERYQ is the first…
schaeffersresearch.com 4 Biotech Stocks Seeing Unusual Options Volume Today Four pharmaceutical and biotech stocks are seeing unusual options activity today, with Inovio Pharmaceuticals Inc (NASDAQ:INO), Aquestive Therapeutics Inc (NASDAQ:AQST), X4 Pharmaceuticals Inc…
prnewswire.com INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026 PLYMOUTH MEETING, Pa., Nov. 2, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus…
prnewswire.com INOVIO to Participate in Upcoming Scientific Conferences PLYMOUTH MEETING, Pa., Nov. 2, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
seekingalpha.com Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
benzinga.com Crude Oil Tumbles 7%; ISM Manufacturing PMI Rises In October U.S. stocks climbed as manufacturing data beat estimates; consumer shares surged, oil fell 7%, and Inovio, Perion and Evgo rallied.
benzinga.com Inovio Stock Soars Following FDA Approval for Rare Respiratory Disease Immunotherapy Inovio stock surges after FDA accelerated approval of Voceryq, an immunotherapy reducing surgeries for adults with recurrent respiratory papillomatosis.
marketbeat.com Inovio Wins FDA Approval for VOCERYQ, Its First Commercial Product Inovio Pharmaceuticals NASDAQ: INO said the U.S. Food and Drug Administration granted accelerated approval to VOCERYQ, formerly known as INO-3107, as a nonsurgical treatment intended to reduce the…
benzinga.com Dow Jumps Over 400 Points; Marriott Posts Upbeat Q3 Earnings U.S. stocks rose Monday, led by a 400-point Dow gain. Marriott beat estimates; Inovio surged 195%, while oil fell 6% and Karyopharm sank 79%.
benzinga.com Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Rise Ahead of Apple, Palantir Earnings; RYAAY, USLM, INO in Focus (UPDATED) U.S. stocks rose on Monday, as the Dow Jones, S&P 500, and Nasdaq 100 index futures advanced, following Friday's lower close.
benzinga.com This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday Analysts upgraded PMT, MHK, CRWD, INO and AON; targets rose for MHK, CRWD and INO, while PMT’s target fell.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…
benzinga.com HC Wainwright & Co. Upgrades Inovio Pharmaceuticals to Buy, Announces $5 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.
benzinga.com Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) rose sharply in pre-market trading after the company disclosed that the FDA has granted accelerated approval for Voceryq for the treatment of adults…
benzinga.com Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket Inovio shares surged 230% premarket after FDA accelerated Voceryq approval; ClearOne and 22nd Century gained, while RedCloud fell 33.5%.
benzinga.com Apple, Marriott International and 3 Stocks to Watch Heading Into Monday Stocks in focus: Apple, Marriott and Estée Lauder report earnings; Inovio wins FDA approval, while U.S. Lime posts disappointing results.
prnewswire.com INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and debilitating disease that often requires surgery VOCERYQ™ is a plasmid DNA-based…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 292.6% to $2.37 during Friday's after-market session. The market value of their outstanding shares is at $79.8 million. Capricor…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA)…
prnewswire.com INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science PLYMOUTH MEETING, Pa., Oct. 20, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and…
defenseworld.net Critical Survey: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO) Pyxis Oncology (NASDAQ: PYXS - Get Free Report) and Inovio Pharmaceuticals (NASDAQ: INO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the…
zacks.com Bet on 4 Top-Ranked Stocks With Rising P/E Tap four stocks with increasing P/E ratios to try out an out-of-the-box investment approach.
seekingalpha.com Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript
marketbeat.com Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms Inovio Pharmaceuticals NASDAQ: INO said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and…
marketbeat.com Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP Inovio Pharmaceuticals NASDAQ: INO is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory papillomatosis, or RRP, President and CEO Jacky Shea…
benzinga.com World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report
benzinga.com Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3 Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.
benzinga.com Inovio Pharmaceuticals Q2 EPS $(0.07) Beats $(0.22) Estimate Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.22) by 68.18 percent. This is a 88.52 percent increase over losses…- benzinga.com Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $4 Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $6 to $4.
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
benzinga.com Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%, communication services down 3.3%. Microsoft jumps 15% after strong earnings.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
benzinga.com Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.
benzinga.com Inovio Stock Falls 21% After Hours: Here's What's Going On Inovio stock fell after hours after pricing a $20 million public offering of common stock and warrants.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at…
- benzinga.com INOVIO Pharmaceuticals Announces Proposed Public Offering Of Shares And Warrants INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and…